Real-world impact of antifibrotics on prognosis in patients with progressive fibrosing interstitial lung disease

OBJECTIVE: No studies have demonstrated the real-world efficacy of antifibrotics for progressive fibrosing interstitial lung disease (PF-ILD). Therefore, we evaluated the efficacy of antifibrotics in patients with PF-ILD. METHODS: We retrospectively reviewed the medical records of patients with ILD...

Descripción completa

Detalles Bibliográficos
Autores principales: Niitsu, Takayuki, Fukushima, Kiyoharu, Komukai, Sho, Takata, So, Abe, Yuko, Nii, Takuro, Kuge, Tomoki, Iwakoshi, Shinichi, Shiroyama, Takayuki, Miyake, Kotaro, Tujino, Kazuyuki, Tanizaki, Satoshi, Iwahori, Kota, Hirata, Haruhiko, Miki, Keisuke, Yanagawa, Masahiro, Takeuchi, Noriyuki, Takeda, Yoshito, Kida, Hiroshi, Kumanogoh, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Treatments
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872509/
https://www.ncbi.nlm.nih.gov/pubmed/36690385
http://dx.doi.org/10.1136/rmdopen-2022-002667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872509/
https://www.ncbi.nlm.nih.gov/pubmed/36690385
http://dx.doi.org/10.1136/rmdopen-2022-002667

Ejemplares similares